SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-17-128667
Filing Date
2017-04-19
Accepted
2017-04-19 15:17:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d374253dsc13ga.htm SC 13G/A 49294
  Complete submission text file 0001193125-17-128667.txt   50692
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-46083 | Film No.: 17769837
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3653 MAPLEWOOD AVENUE DALLAS TX 75205
Business Address
MEAD ROBERT E (Filed by) CIK: 0001040747 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000